xconomy.com xconomy.com - O resultado é de 60/100

Avaliação do site xconomy.com

 Gerado a 15 de Outubro de 2026 13:45 PM

Estatísticas desatualizadas? ATUALIZE !

O resultado é de 60/100





Advertisement

Conteúdo SEO

Título

BioXconomy

Cumprimento : 10

Idealmente, o Título deve conter entre 40 e 70 caracteres (incluíndo espaços).

Descrição

BioXconomy provides information and insights for life sciences investment, innovation and partnering.

Cumprimento : 101

Perfeito, a Descrição META contém entre 90 e 160 caracteres.

Palavras-chave

Mau. Não detetámos palavras-chave META na sua página.

Propriedades Og Meta

Boa! Esta página tira vantagens das propriedades Og.

Propriedade Conteúdo
title BioXconomy
description BioXconomy provides information and insights for life sciences investment, innovation and partnering.
url https://www.bioxconomy.com/
type website
image https://eu-images.contentstack.com/v3/assets/blt72fb3b8b4630b7db/blt25617c776391716f/6a7e58393f96871c9f61f984/BioXconomy-opengraph-2.jpg?disable=upscale&width=1200&height=630&fit=crop
site_name BioXconomy

Cabeçalhos

H1 H2 H3 H4 H5 H6
0 3 9 8 4 0
  • [H2] Latest News
  • [H2] Blood-brain barrier repair peptide could hold promise for ALS patients
  • [H2] Blood-brain barrier repair peptide could hold promise for ALS patients
  • [H3] IgniteData, RealTime eClinical Solutions announce data transfer partnership
  • [H3] OMass bags $310m to push rare disease drugs forward
  • [H3] Zealand Pharma generates metabolic therapeutics with AI platform
  • [H3] Bluesky and X users share clinical trial information in markedly different ways, new research shows
  • [H3] Dose of Discovery Podcast, Season 1
  • [H3] Watch the latest presentations coming from our recent partnering events
  • [H3] News from APAC
  • [H3] Interviews
  • [H3] AI in Life Sciences
  • [H4] Related Topics
  • [H4] Recent in Partnering
  • [H4] Related Topics
  • [H4] Recent in Investment
  • [H4] Related Topics
  • [H4] Recent in Modalities
  • [H4] Related Topics
  • [H4] Recent in Business Strategy
  • [H5] Resources
  • [H5] Connect
  • [H5] Join Us
  • [H5] Follow Us

Imagens

Encontrámos 54 imagens nesta página.

4 atributos ALT estão vazios ou em falta. É recomendado adicionar texto alternativo de modo a que os motores de busca identifiquem melhor o conteúdo das suas imagens.

Rácio Texto/HTML

Rácio : 3%

O rácio de texto para código HTML desta página é menor que 20 porcento, o que significa que provavelmente é necessário de adicionar mais conteúdos em forma de texto.

Iframe

Oh, não, esta página tem Iframes na página, o que significa que o conteúdo destas não pode ser indexado.

Reescrita de URL

Perfeito. As ligações aparentam ser limpas!

Underscores (traços inferiores) nas URLs

Perfeito. Não foram encontrados 'underscores' (traços inferiores) nas suas URLs.

Ligações para a própria página

Encontrámos um total de 73 ligações incluindo 0 ligações a ficheiros

Âncoras Tipo Sumo
Informa PLC Externas Passa sumo
ABOUT US Externas Passa sumo
INVESTOR RELATIONS Externas Passa sumo
TALENT Externas Passa sumo
About Internas Passa sumo
Events Internas Passa sumo
Advertise Externas Passa sumo
Licensing Internas Passa sumo
M&A Internas Passa sumo
Growth Strategy Internas Passa sumo
Partnering Internas Passa sumo
Zealand Pharma generates metabolic therapeutics with AI platform Internas Passa sumo
Nnenna Ohaka Internas Passa sumo
Danaher and NVIDIA partner on AI-driven lab automation Internas Passa sumo
Millie Nelson Internas Passa sumo
VC/PE Internas Passa sumo
Seed Funding Internas Passa sumo
IPOs Internas Passa sumo
Investment Internas Passa sumo
OMass bags $310m to push rare disease drugs forward Internas Passa sumo
Stryker bets big on robot surgery, backing CMR Surgical in $400m deal Internas Passa sumo
Nucleic Acids Internas Passa sumo
Antibodies and Peptides Internas Passa sumo
Advanced Therapies Internas Passa sumo
Modalities Internas Passa sumo
Rethinking Expression to Accelerate Antibody Discovery Internas Passa sumo
Blood-brain barrier repair peptide could hold promise for ALS patients Internas Passa sumo
Søren Hough Internas Passa sumo
Compliance, Regulatory and Legal Internas Passa sumo
Access and Channel Internas Passa sumo
Finance and Accounting Internas Passa sumo
Clinical Trials Internas Passa sumo
Pricing and Contracting Internas Passa sumo
Business Strategy Internas Passa sumo
Optimizing the Affordability Journey: Insights from a Real-World Brand Case Study Internas Passa sumo
IgniteData, RealTime eClinical Solutions announce data transfer partnership Internas Passa sumo
EMA to make EU-level trial advice pilot a permanent option for sponsors Internas Passa sumo
Dose of Discovery: Katalin Karikó on the mRNA breakthrough that changed medicine Internas Passa sumo
Dose of Discovery: Anne Conibear on how small changes reshape peptide and protein biology Internas Passa sumo
Dose of Discovery: Erik Sontheimer on the evolution of genome editing Internas Passa sumo
Dose of Discovery: Cheng Yi Chen on scaling drugs from lab to launch Internas Passa sumo
Dose of Discovery: Stanley Crooke on fixing nano-rare disease with oligos Internas Passa sumo
Dose of Discovery: Julia Alterman on expanding RNA therapeutics Internas Passa sumo
Dose of Discovery: Debut trailer Internas Passa sumo
Eyes on Asia: TCGX, Biohaven, Roche Internas Passa sumo
Shionogi bolsters rare disease portfolio with $2bn IntraBio buy Internas Passa sumo
The hidden cost of going global: How most favored nation pricing is reshaping rare disease launches Internas Passa sumo
Brandy Fidler Internas Passa sumo
SEC-FDA pact tightens disclosure rules for pharma Internas Passa sumo
Lisa Henderson Internas Passa sumo
Medtech firms embrace embedded digital compliance Internas Passa sumo
Tarn Brown Internas Passa sumo
DaltonTx announces AI breakthrough in novel antibody discovery Internas Passa sumo
Millie Hoe Internas Passa sumo
HHS launches initiative to bolster US clinical trials market Internas Passa sumo
Gareth Macdonald Internas Passa sumo
Protect IP theft from vast datasets used in AI Internas Passa sumo
Recruitment challenges, delays, and AI reshaping trials sector, survey finds Internas Passa sumo
Veeva unveils AI agent to speed clinical trial study configuration Internas Passa sumo
Rethinking biotech investment and innovation in a productivity-driven era Internas Passa sumo
Brick by brick: How AI-native biotechs are building investor confidence Internas Passa sumo
How AI is streamlining patient support behind the scenes Internas Passa sumo
AI drug hunter Iambic files for Nasdaq IPO Internas Passa sumo
Enveda’s $311m Series E to fund AI-driven drug discovery Internas Passa sumo
Webinars Internas Passa sumo
Podcasts Internas Passa sumo
Innovation Showcase Internas Passa sumo
Partner Videos Internas Passa sumo
Contribute Internas Passa sumo
About Informa Externas Passa sumo
Contact Informa Externas Passa sumo
Privacy Externas Passa sumo
Terms Externas Passa sumo
Advertisement

Palavras-chave SEO

Núvem de palavras-chave

dose      discovery      now      playarrow      read      oct      presents      lsx      min      chevronright     

Consistência das Palavras-chave

Palavra-chave Conteúdo Título Palavras-chave Descrição Cabeçalhos
oct 22
discovery 22
lsx 21
min 20
presents 19

Usabilidade

Url

Domínio : xconomy.com

Cumprimento : 11

Favicon

Ótimo, o site tem um favicon.

Língua

Otimo! A língua declarada deste site é en.

Documento

Tipo de Documento

HTML 5

Codificação

Perfeito. O conjunto de caracteres UTF-8 está declarado.

Privacidade do Email

Boa! Nenhum endereço de email está declarado sob a forma de texto!

HTML obsoleto

Fantástico! Não detetámos etiquetas HTML obsoletas.

Dicas de Velocidade

Oh não, o site usa estilos CSS nas etiquetas HTML.
Oh, não! O site utiliza demasiados ficheiros CSS (mais que 4).
Perfeito, o site usa poucos ficheiros JavaScript.
Perfeito, o site tira vantagens da compressão gzip.

Dispositivos Móveis

Otimização para dispositivos móveis

Icon Apple
Meta Viewport Tag
Advertisement

Otimização

XML Sitemap

Perfeito, o site tem um mapa XML do site (sitemap).

https://www.bioxconomy.com/sitemap.xml
https://www.bioxconomy.com/googlenews.xml
https://www.bioxconomy.com/contributors.xml
https://www.bioxconomy.com/generic-content.xml
https://www.bioxconomy.com/image-archive-index.xml
https://www.bioxconomy.com/news-archive-index.xml
https://www.bioxconomy.com/event-archive-index.xml
https://www.bioxconomy.com/articles-archive-index.xml
https://www.bioxconomy.com/videos-archive-index.xml
https://www.bioxconomy.com/webinar-archive-index.xml
https://www.bioxconomy.com/podcast-archive-index.xml
https://www.bioxconomy.com/multi-section-article-archive-index.xml
https://www.bioxconomy.com/publication-issue-archive-index.xml
https://www.bioxconomy.com/document-archive-index.xml
https://www.bioxconomy.com/sitemap-index.xml
https://www.bioxconomy.com/ads.txt

Robots.txt

http://xconomy.com/robots.txt

Perfeito, o seu site tem um ficheiro robots.txt.

Analytics

Em falta

Não detetámos nenhuma ferramenta analítica de análise de atividade.

Este tipo de ferramentas (como por exemplo o Google Analytics) permite perceber o comportamento dos visitantes e o tipo de atividade que fazem. No mínimo, uma ferramenta deve estar instalada, sendo que em algumas situações mais do que uma pode ser útil.

AI Search Readiness

AI Crawlers

AI search crawlers are allowed, so the site can be shown and cited in AI answers (ChatGPT, Claude, Perplexity).

OAI-SearchBot ChatGPT search AI search
ChatGPT-User ChatGPT (user requests) AI search
Claude-SearchBot Claude search AI search
Claude-User Claude (user requests) AI search
PerplexityBot Perplexity AI search
GPTBot OpenAI training AI training
ClaudeBot Anthropic training AI training
Google-Extended Google Gemini training AI training
Applebot-Extended Apple AI training AI training
CCBot Common Crawl AI training

Blocking AI training crawlers is a common choice and doesn't affect the score. Only the AI search crawlers count.

Structured Data

The homepage describes itself with schema.org structured data, which helps search engines and AI tools understand it: NewsMediaOrganization, ImageObject, QuantitativeValue

Canonical Tag

The homepage has a canonical tag, which tells search engines which URL is the main version of the page.

llms.txt

No llms.txt file. It's an emerging convention: a short Markdown summary of the site for AI tools. Optional, so it doesn't affect the score.

Security

HTTPS

The site loads over HTTPS, so connections are encrypted. Browsers and search engines expect this.

HSTS

The site sends a Strict-Transport-Security header, so browsers always use HTTPS for it.

Security Headers

1 of 5 common security headers found. At least 2 are needed to pass.

Content-Security-Policy
X-Content-Type-Options
X-Frame-Options
Referrer-Policy
Permissions-Policy
Checked on 15 Oct 2026.

Domain Info

xconomy.com was registered on 25 Aug 2006 with SafeNames Ltd. and expires on 25 Aug 2027. It has no mail server (MX) records. The Wayback Machine first archived it in April 2001.

Registration

Registrar SafeNames Ltd.
Registered 25 Aug 2006 (20 years ago)
Expires 25 Aug 2027
Last changed 25 Aug 2026
Nameservers james.ns.cloudflare.com, marge.ns.cloudflare.com
DNSSEC Signed

Hosting

IPv4 address 172.67.128.87, 104.21.0.223
IPv6 support

Email Security

This domain has no mail server (MX) records, so it doesn't receive email.

SPF record
DMARC record (policy: quarantine)

Archive History

The Wayback Machine has snapshots of this site from 189 different months, from April 2001 to February 2026. View snapshots

Domain data checked on 15 Oct 2026. Sources: registry RDAP, public DNS, Internet Archive.

PageSpeed Insights


Dispositivo
Categorias

Advertisement

GoInfosystems

GoInfosystems é uma ferramenta gratuita que o ajuda a avaliar o seu site